Methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate
C21H24FNO5 — CID 122623277
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate
Methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate (PubChem CID 122623277) has the molecular formula C21H24FNO5 and a molecular weight of 389.42 g/mol. Its IUPAC name is methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate.
Molecular Properties
| Compound Name | Methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate |
|---|---|
| PubChem CID | 122623277 |
| Molecular Formula | C21H24FNO5 |
| Molecular Weight | 389.42 g/mol |
| Exact Mass | 389.16 |
| IUPAC Name | methyl 3-(4-fluorophenyl)-4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]benzoate |
| SMILES | COC(=O)c1ccc(OCCNC(=O)OC(C)(C)C)c(-c2ccc(F)cc2)c1 |
| InChI | InChI=1S/C21H24FNO5/c1-21(2,3)28-20(25)23-11-12-27-18-10-7-15(19(24)26-4)13-17(18)14-5-8-16(22)9-6-14/h5-10,13H,11-12H2,1-4H3,(H,23,25) |
| InChIKey | HEGZMPKBDJGCLS-UHFFFAOYSA-N |
| XLogP | 4.18 |
| TPSA | 73.86 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.42 |
| LogP ≤ 5 | 4.18 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122623277 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.